Zoe Efstathiadou

1.8k total citations
61 papers, 1.4k citations indexed

About

Zoe Efstathiadou is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology. According to data from OpenAlex, Zoe Efstathiadou has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Zoe Efstathiadou's work include Pituitary Gland Disorders and Treatments (18 papers), Growth Hormone and Insulin-like Growth Factors (16 papers) and Bone health and treatments (15 papers). Zoe Efstathiadou is often cited by papers focused on Pituitary Gland Disorders and Treatments (18 papers), Growth Hormone and Insulin-like Growth Factors (16 papers) and Bone health and treatments (15 papers). Zoe Efstathiadou collaborates with scholars based in Greece, United States and United Kingdom. Zoe Efstathiadou's co-authors include Stergios A. Pοlyzos, Marina Κita, Athanasios D. Anastasilakis, Agathocles Tsatsoulis, Polyzois Makras, Panagiotis Anagnostis, John P. A. Ioannidis, Јannis Kountouras, Christos S. Mantzoros and Nikolaos Perakakis and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research and Diabetologia.

In The Last Decade

Zoe Efstathiadou

59 papers receiving 1.3k citations

Peers

Zoe Efstathiadou
Marie Bex Belgium
Seong Yeon Kim South Korea
Tomaž Kocjan Slovenia
G. Leb Austria
Mi Zhou China
Marie Bex Belgium
Zoe Efstathiadou
Citations per year, relative to Zoe Efstathiadou Zoe Efstathiadou (= 1×) peers Marie Bex

Countries citing papers authored by Zoe Efstathiadou

Since Specialization
Citations

This map shows the geographic impact of Zoe Efstathiadou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoe Efstathiadou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoe Efstathiadou more than expected).

Fields of papers citing papers by Zoe Efstathiadou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoe Efstathiadou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoe Efstathiadou. The network helps show where Zoe Efstathiadou may publish in the future.

Co-authorship network of co-authors of Zoe Efstathiadou

This figure shows the co-authorship network connecting the top 25 collaborators of Zoe Efstathiadou. A scholar is included among the top collaborators of Zoe Efstathiadou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoe Efstathiadou. Zoe Efstathiadou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Efstathiadou, Zoe, Αlexandra Bargiota, Vasiliki Daraki, et al.. (2020). Benefits and Limitations of TKIs in Patients with Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis. European Thyroid Journal. 10(2). 125–139. 21 indexed citations
3.
Efstathiadou, Zoe, Marina Κita, & Stergios A. Pοlyzos. (2018). Thyroid dysfunction and non-alcoholic fatty liver disease. Minerva Endocrinology. 43(3). 367–376. 13 indexed citations
4.
Efstathiadou, Zoe, Αlexandra Bargiota, Alexandra Chrisoulidou, et al.. (2015). Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis. Pituitary. 18(6). 861–867. 35 indexed citations
5.
Anastasilakis, Athanasios D., Stergios A. Pοlyzos, Zoe Efstathiadou, et al.. (2015). Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers. Metabolism. 64(10). 1291–1297. 24 indexed citations
6.
Anagnostis, Panagiotis, et al.. (2014). Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?. Endocrine. 47(2). 564–571. 31 indexed citations
7.
Efstathiadou, Zoe, et al.. (2012). Oxidative stress and reduced anti-oxidative status, along with endothelial dysfunction in acromegaly. 15th International & 14th European Congress of Endocrinology. 29. 8 indexed citations
8.
Anagnostis, Panagiotis, et al.. (2011). Acromegaly: presentation, morbidity and treatment outcomes at a single centre. International Journal of Clinical Practice. 65(8). 896–902. 36 indexed citations
9.
Anagnostis, Panagiotis, et al.. (2011). Pituitary incidentalomas: a single-centre experience. International Journal of Clinical Practice. 65(2). 172–177. 31 indexed citations
10.
Efstathiadou, Zoe, et al.. (2010). Associations of Estrogen Receptor Alpha and Beta Gene Polymorphisms with Sex Steroid Levels and Body Fat Content in Men. Experimental and Clinical Endocrinology & Diabetes. 120(3). 154–159. 6 indexed citations
11.
Pοlyzos, Stergios A., Athanasios D. Anastasilakis, Zoe Efstathiadou, et al.. (2010). Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget’s disease. Journal of Bone and Mineral Metabolism. 28(6). 706–712. 21 indexed citations
12.
Pοlyzos, Stergios A., Athanasios D. Anastasilakis, Zoe Efstathiadou, et al.. (2009). Serum homocysteine, folate and vitamin B12 in patients with Paget’s disease of bone: the effect of zoledronic acid. Journal of Bone and Mineral Metabolism. 28(3). 314–319. 7 indexed citations
13.
Κita, Marina, et al.. (2008). Primary Adrenal Lymphoma Presenting as Addison's Disease. Case Report and Review of the Literature. Experimental and Clinical Endocrinology & Diabetes. 116(6). 363–365. 8 indexed citations
14.
Anastasilakis, Athanasios D., et al.. (2008). Effect of Exogenous Intermittent Recombinant Human PTH 1–34 Administration and Chronic Endogenous Parathyroid Hormone Excess on Glucose Homeostasis and Insulin Sensitivity. Hormone and Metabolic Research. 40(10). 702–707. 21 indexed citations
15.
Efstathiadou, Zoe, et al.. (2007). Long‐term changes and variability in diabetes risk factors prior to the development of impaired glucose homeostasis. Diabetic Medicine. 24(11). 1269–1278. 14 indexed citations
16.
Κousta, Eleni, Zoe Efstathiadou, Natasha Lawrence, et al.. (2005). The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes. Diabetologia. 49(1). 36–40. 58 indexed citations
17.
18.
Κousta, Eleni, Zoe Efstathiadou, Natalia Lawrence, et al.. (2002). CONSEQUENCES OF PREVIOUS GESTATIONAL DIABETES ON ASPECTS OF THE METABOLIC SYNDROME. 1 indexed citations
19.
Efstathiadou, Zoe & Agathocles Tsatsoulis. (2001). Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist. Fertility and Sterility. 75(1). 59–62. 11 indexed citations
20.
Efstathiadou, Zoe, et al.. (1999). Gastrectomy and Osteomalacia: An Association Not to Be Forgotten. Hormone Research in Paediatrics. 52(6). 295–297. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026